Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Beckmann

Showing results (811-820 of 1,041) with videos related to

Pageof 105
Sort By:
Breast Cancer Research and Treatment|October 17, 2018
Efficacy of neoadjuvant pertuzumab in addition to chemotherapy and trastuzumab in routine clinical treatment of patients with primary breast cancer: a multicentric analysisPeter A Fasching, Andreas D Hartkopf, Paul Gass, et al.
NPJ Breast Cancer|July 13, 2024
Susceptibility gene mutations in germline and tumors of patients with HER2-negative advanced breast cancerPeter A Fasching, Chunling Hu, Steven N Hart, et al.
European Journal of Cancer (Oxford, England : 1990)|July 15, 2021
Disseminated tumour cells from the bone marrow of early breast cancer patients: Results from an international pooled analysisAndreas D Hartkopf, Sara Y Brucker, Florin-Andrei Taran, et al.
European Journal of Cancer (Oxford, England : 1990)|June 9, 2024
The WERA cancer center matrix: Strategic management of patient access to precision oncology in a large and mostly rural area of GermanyMarkus Krebs, Florian Haller, Silvia Spörl, et al.
Geburtshilfe Und Frauenheilkunde|April 19, 2021
Diagnosis and Treatment of Endometriosis. Guideline of the DGGG, SGGG and OEGGG (S2k Level, AWMF Registry Number 015/045, August 2020)Stefanie Burghaus, Sebastian D Schäfer, Matthias W Beckmann, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 29, 2021
Mutations in <i>BRCA1/2</i> and Other Panel Genes in Patients With Metastatic Breast Cancer -Association With Patient and Disease Characteristics and Effect on PrognosisPeter A Fasching, Siddhartha Yadav, Chunling Hu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 22, 2005
Prediction of BRCA1 status in patients with breast cancer using estrogen receptor and basal phenotypeSunil R Lakhani, Jorge S Reis-Filho, Laura Fulford, et al.
Plos One|June 16, 2011
Estrogen receptor beta rs1271572 polymorphism and invasive ovarian carcinoma risk: pooled analysis within the Ovarian Cancer Association ConsortiumGalina Lurie, Lynne R Wilkens, Pamela J Thompson, et al.
British Journal of Cancer|August 2, 2012
PREDICT Plus: development and validation of a prognostic model for early breast cancer that includes HER2G C Wishart, C D Bajdik, E Dicks, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 3, 2014
Inherited mutations in 17 breast cancer susceptibility genes among a large triple-negative breast cancer cohort unselected for family history of breast cancerFergus J Couch, Steven N Hart, Priyanka Sharma, et al.
Pageof 105

Showing results (811-820 of 1,041) with videos related to

Sort By:
Pageof 105
Breast Cancer Research and Treatment|October 17, 2018
Efficacy of neoadjuvant pertuzumab in addition to chemotherapy and trastuzumab in routine clinical treatment of patients with primary breast cancer: a multicentric analysisPeter A Fasching, Andreas D Hartkopf, Paul Gass, et al.
NPJ Breast Cancer|July 13, 2024
Susceptibility gene mutations in germline and tumors of patients with HER2-negative advanced breast cancerPeter A Fasching, Chunling Hu, Steven N Hart, et al.
European Journal of Cancer (Oxford, England : 1990)|July 15, 2021
Disseminated tumour cells from the bone marrow of early breast cancer patients: Results from an international pooled analysisAndreas D Hartkopf, Sara Y Brucker, Florin-Andrei Taran, et al.
European Journal of Cancer (Oxford, England : 1990)|June 9, 2024
The WERA cancer center matrix: Strategic management of patient access to precision oncology in a large and mostly rural area of GermanyMarkus Krebs, Florian Haller, Silvia Spörl, et al.
Geburtshilfe Und Frauenheilkunde|April 19, 2021
Diagnosis and Treatment of Endometriosis. Guideline of the DGGG, SGGG and OEGGG (S2k Level, AWMF Registry Number 015/045, August 2020)Stefanie Burghaus, Sebastian D Schäfer, Matthias W Beckmann, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 29, 2021
Mutations in <i>BRCA1/2</i> and Other Panel Genes in Patients With Metastatic Breast Cancer -Association With Patient and Disease Characteristics and Effect on PrognosisPeter A Fasching, Siddhartha Yadav, Chunling Hu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 22, 2005
Prediction of BRCA1 status in patients with breast cancer using estrogen receptor and basal phenotypeSunil R Lakhani, Jorge S Reis-Filho, Laura Fulford, et al.
Plos One|June 16, 2011
Estrogen receptor beta rs1271572 polymorphism and invasive ovarian carcinoma risk: pooled analysis within the Ovarian Cancer Association ConsortiumGalina Lurie, Lynne R Wilkens, Pamela J Thompson, et al.
British Journal of Cancer|August 2, 2012
PREDICT Plus: development and validation of a prognostic model for early breast cancer that includes HER2G C Wishart, C D Bajdik, E Dicks, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 3, 2014
Inherited mutations in 17 breast cancer susceptibility genes among a large triple-negative breast cancer cohort unselected for family history of breast cancerFergus J Couch, Steven N Hart, Priyanka Sharma, et al.
Pageof 105